APO RESEARCH · REPORT
Complete Nutritional Formula Food for Malnourished Patients
Selected research
Market Structure
Global Complete Nutritional Formula Food for Malnourished Patients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Complete Nutritional Formula Food for Malnourished Patients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Complete Nutritional Formula Food for Malnourished Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Complete Nutritional Formula Food for Malnourished Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Complete Nutritional Formula Food for Malnourished Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Complete Nutritional Formula Food for Malnourished Patients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Complete Nutritional Formula Food for Malnourished Patients include Abbott, Nestlé, NUTRICIA, Fresenius, Ajinomoto, MeadJohnson, BOSSD, Bayer and EnterNutr, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Complete Nutritional Formula Food for Malnourished Patients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Complete Nutritional Formula Food for Malnourished Patients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Complete Nutritional Formula Food for Malnourished Patients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Complete Nutritional Formula Food for Malnourished Patients market size, projected growth trends, production technologies, key applications, and end-use industries.
Complete Nutritional Formula Food for Malnourished Patients Segment by Company
Abbott
Nestlé
NUTRICIA
Fresenius
Ajinomoto
MeadJohnson
BOSSD
Bayer
EnterNutr
Anhui New Health Biotechnology
Bangsidi Biotechnology
Dongze Special Medical Food
Special Biotechnology
Haisike Pharmaceutical
Xi'an Libang Clinical Nutrition
Complete Nutritional Formula Food for Malnourished Patients Segment by Type
Gel Food
Porous Food
Powdered Food
Pasty Food
Milky Food
Others
Complete Nutritional Formula Food for Malnourished Patients Segment by Application
Hospital
Pharmacy
Others
Complete Nutritional Formula Food for Malnourished Patients Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complete Nutritional Formula Food for Malnourished Patients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Complete Nutritional Formula Food for Malnourished Patients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complete Nutritional Formula Food for Malnourished Patients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Complete Nutritional Formula Food for Malnourished Patients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complete Nutritional Formula Food for Malnourished Patients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complete Nutritional Formula Food for Malnourished Patients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Complete Nutritional Formula Food for Malnourished Patients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Gel Food
- Porous Food
- Powdered Food
- Pasty Food
- Milky Food
- Others
Applications
- Hospital
- Pharmacy
- Others
Companies covered
- Abbott
- Nestlé
- NUTRICIA
- Fresenius
- Ajinomoto
- MeadJohnson
- BOSSD
- Bayer
- EnterNutr
- Anhui New Health Biotechnology
- Bangsidi Biotechnology
- Dongze Special Medical Food
- Special Biotechnology
- Haisike Pharmaceutical
- Xi'an Libang Clinical Nutrition
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Complete Nutritional Formula Food for Malnourished Patients Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Complete Nutritional Formula Food for Malnourished Patients Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Complete Nutritional Formula Food for Malnourished Patients Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Complete Nutritional Formula Food for Malnourished Patients Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Complete Nutritional Formula Food for Malnourished Patients Market Dynamics
- 2.1 Complete Nutritional Formula Food for Malnourished Patients Industry Trends
- 2.2 Complete Nutritional Formula Food for Malnourished Patients Industry Drivers
- 2.3 Complete Nutritional Formula Food for Malnourished Patients Industry Opportunities and Challenges
- 2.4 Complete Nutritional Formula Food for Malnourished Patients Industry Restraints
3 Complete Nutritional Formula Food for Malnourished Patients Market by Manufacturers
- 3.1 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Manufacturers (2021-2026)
- 3.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Manufacturers (2021-2026)
- 3.3 Global Complete Nutritional Formula Food for Malnourished Patients Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Complete Nutritional Formula Food for Malnourished Patients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Complete Nutritional Formula Food for Malnourished Patients Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Complete Nutritional Formula Food for Malnourished Patients Manufacturers, Product Type & Application
- 3.7 Global Complete Nutritional Formula Food for Malnourished Patients Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Complete Nutritional Formula Food for Malnourished Patients Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Complete Nutritional Formula Food for Malnourished Patients Players Market Share by Revenue in 2025
- 3.8.3 2025 Complete Nutritional Formula Food for Malnourished Patients Tier 1, Tier 2, and Tier 3
4 Complete Nutritional Formula Food for Malnourished Patients Market by Type
- 4.1 Complete Nutritional Formula Food for Malnourished Patients Type Introduction
- 4.1.1 Gel Food
- 4.1.2 Porous Food
- 4.1.3 Powdered Food
- 4.1.4 Pasty Food
- 4.1.5 Milky Food
- 4.1.6 Others
- 4.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Type
- 4.2.1 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Type (2021-2032)
- 4.2.3 Global Complete Nutritional Formula Food for Malnourished Patients Sales Market Share by Type (2021-2032)
- 4.3 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Type
- 4.3.1 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Type (2021-2032)
- 4.3.3 Global Complete Nutritional Formula Food for Malnourished Patients Revenue Market Share by Type (2021-2032)
5 Complete Nutritional Formula Food for Malnourished Patients Market by Application
- 5.1 Complete Nutritional Formula Food for Malnourished Patients Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.1.3 Others
- 5.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Application
- 5.2.1 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Application (2021-2032)
- 5.2.3 Global Complete Nutritional Formula Food for Malnourished Patients Sales Market Share by Application (2021-2032)
- 5.3 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Application
- 5.3.1 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Application (2021-2032)
- 5.3.3 Global Complete Nutritional Formula Food for Malnourished Patients Revenue Market Share by Application (2021-2032)
6 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Region
- 6.1 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Region (2021-2032)
- 6.2.1 Global Complete Nutritional Formula Food for Malnourished Patients Sales by Region (2021-2026)
- 6.2.2 Global Complete Nutritional Formula Food for Malnourished Patients Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Complete Nutritional Formula Food for Malnourished Patients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Complete Nutritional Formula Food for Malnourished Patients Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Complete Nutritional Formula Food for Malnourished Patients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Complete Nutritional Formula Food for Malnourished Patients Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Complete Nutritional Formula Food for Malnourished Patients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Complete Nutritional Formula Food for Malnourished Patients Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Complete Nutritional Formula Food for Malnourished Patients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Complete Nutritional Formula Food for Malnourished Patients Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Region
- 7.1 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Region
- 7.1.1 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Region (2021-2026)
- 7.1.3 Global Complete Nutritional Formula Food for Malnourished Patients Revenue by Region (2027-2032)
- 7.1.4 Global Complete Nutritional Formula Food for Malnourished Patients Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Complete Nutritional Formula Food for Malnourished Patients Revenue (2021-2032)
- 7.2.2 North America Complete Nutritional Formula Food for Malnourished Patients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Complete Nutritional Formula Food for Malnourished Patients Revenue (2021-2032)
- 7.3.2 Europe Complete Nutritional Formula Food for Malnourished Patients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Complete Nutritional Formula Food for Malnourished Patients Revenue (2021-2032)
- 7.4.2 Asia-Pacific Complete Nutritional Formula Food for Malnourished Patients Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Complete Nutritional Formula Food for Malnourished Patients Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Complete Nutritional Formula Food for Malnourished Patients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott
- 8.1.1 Abbott Company Information
- 8.1.2 Abbott Business Overview
- 8.1.3 Abbott Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.1.5 Abbott Recent Developments
- 8.2 Nestlé
- 8.2.1 Nestlé Company Information
- 8.2.2 Nestlé Business Overview
- 8.2.3 Nestlé Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Nestlé Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.2.5 Nestlé Recent Developments
- 8.3 NUTRICIA
- 8.3.1 NUTRICIA Company Information
- 8.3.2 NUTRICIA Business Overview
- 8.3.3 NUTRICIA Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 NUTRICIA Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.3.5 NUTRICIA Recent Developments
- 8.4 Fresenius
- 8.4.1 Fresenius Company Information
- 8.4.2 Fresenius Business Overview
- 8.4.3 Fresenius Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Fresenius Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.4.5 Fresenius Recent Developments
- 8.5 Ajinomoto
- 8.5.1 Ajinomoto Company Information
- 8.5.2 Ajinomoto Business Overview
- 8.5.3 Ajinomoto Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ajinomoto Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.5.5 Ajinomoto Recent Developments
- 8.6 MeadJohnson
- 8.6.1 MeadJohnson Company Information
- 8.6.2 MeadJohnson Business Overview
- 8.6.3 MeadJohnson Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 MeadJohnson Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.6.5 MeadJohnson Recent Developments
- 8.7 BOSSD
- 8.7.1 BOSSD Company Information
- 8.7.2 BOSSD Business Overview
- 8.7.3 BOSSD Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 BOSSD Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.7.5 BOSSD Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bayer Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 EnterNutr
- 8.9.1 EnterNutr Company Information
- 8.9.2 EnterNutr Business Overview
- 8.9.3 EnterNutr Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 EnterNutr Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.9.5 EnterNutr Recent Developments
- 8.10 Anhui New Health Biotechnology
- 8.10.1 Anhui New Health Biotechnology Company Information
- 8.10.2 Anhui New Health Biotechnology Business Overview
- 8.10.3 Anhui New Health Biotechnology Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Anhui New Health Biotechnology Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.10.5 Anhui New Health Biotechnology Recent Developments
- 8.11 Bangsidi Biotechnology
- 8.11.1 Bangsidi Biotechnology Company Information
- 8.11.2 Bangsidi Biotechnology Business Overview
- 8.11.3 Bangsidi Biotechnology Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bangsidi Biotechnology Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.11.5 Bangsidi Biotechnology Recent Developments
- 8.12 Dongze Special Medical Food
- 8.12.1 Dongze Special Medical Food Company Information
- 8.12.2 Dongze Special Medical Food Business Overview
- 8.12.3 Dongze Special Medical Food Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Dongze Special Medical Food Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.12.5 Dongze Special Medical Food Recent Developments
- 8.13 Special Biotechnology
- 8.13.1 Special Biotechnology Company Information
- 8.13.2 Special Biotechnology Business Overview
- 8.13.3 Special Biotechnology Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Special Biotechnology Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.13.5 Special Biotechnology Recent Developments
- 8.14 Haisike Pharmaceutical
- 8.14.1 Haisike Pharmaceutical Company Information
- 8.14.2 Haisike Pharmaceutical Business Overview
- 8.14.3 Haisike Pharmaceutical Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Haisike Pharmaceutical Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.14.5 Haisike Pharmaceutical Recent Developments
- 8.15 Xi'an Libang Clinical Nutrition
- 8.15.1 Xi'an Libang Clinical Nutrition Company Information
- 8.15.2 Xi'an Libang Clinical Nutrition Business Overview
- 8.15.3 Xi'an Libang Clinical Nutrition Complete Nutritional Formula Food for Malnourished Patients Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Xi'an Libang Clinical Nutrition Complete Nutritional Formula Food for Malnourished Patients Product Portfolio
- 8.15.5 Xi'an Libang Clinical Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Complete Nutritional Formula Food for Malnourished Patients Value Chain Analysis
- 9.1.1 Complete Nutritional Formula Food for Malnourished Patients Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Complete Nutritional Formula Food for Malnourished Patients Production Mode & Process
- 9.2 Complete Nutritional Formula Food for Malnourished Patients Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Complete Nutritional Formula Food for Malnourished Patients Distributors
- 9.2.3 Complete Nutritional Formula Food for Malnourished Patients Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst